Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 46,068 $ 74,867
Short term investments 40,175 53,240
Accounts receivable 6,952 2,701
Prepaid expenses and other current assets 4,778 4,574
Total current assets 97,973 135,382
Property and equipment, net 11,008 5,049
Other non-current assets 7,770 910
Total assets 116,751 141,341
Current liabilities:    
Accounts payable 5,436 3,350
Accrued expenses and other current liabilities 7,170 9,114
Deferred revenues, current portion 27,242 35,612
Total current liabilities 39,848 48,076
Deferred revenue, net of current portion 44,179 53,303
Other long-term liabilities 12,082 27
Total liabilities 96,109 101,406
Stockholders’ equity:    
Common stock, $0.001 par value per share, 300,000,000 shares authorized and 49,392,706 and 54,151,219 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively 49 54
Additional paid-in capital 194,695 189,929
Accumulated other comprehensive loss (697) (2,982)
Accumulated deficit (173,405) (147,066)
Total stockholders’ equity 20,642 39,935
Total liabilities and stockholders’ equity 116,751 141,341
Series A Convertible, 2,907 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively    
Stockholders’ equity:    
Preferred stock 0 0
Series B Convertible, 5,000 shares issued and outstanding at September 30, 2019. No shares issued and outstanding at December 31, 2018.    
Stockholders’ equity:    
Preferred stock $ 0 $ 0